Valentina Nardi

8PUBLICATIONS
144CO-AUTHORS
Cancer geneticsMolecular targetsHaematological tumoursTumour immunologyCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 11, 2026
Histopathologic, molecular, and clinical associations of fusion-positive gastrointestinal carcinomas.

|May 04, 2026
A novel hyperactive BCR::ABL1 e6a3 variant confers resistance to combined asciminib plus ponatinib therapy.

|Jan 27, 2026
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Viktoria Blumenberg, Filippo Birocchi, Angela Shih

|Dec 16, 2025
Pediatric Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma With Unusually Long Clinical Course.

Carrie Meng, Auris Huen, David McCall

|Jan 18, 2025
Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma with novel FGFR1 fusion treated with pemigatinib.

Carlos A Torres-Cabala, Julia Arreola Yescas, Yue Zhang

|Jul 19, 2023
Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748.

Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos

Pageof 2

Frequent Collaborators

3 joint publications

Aliyah Sohani

3 joint publications

Roberto N Miranda

2 joint publications

Rita Alaggio

2 joint publications

Catalina Amador